Nidogen-2
Nidogen-2 (also known as entactin-2) is a protein that in humans is encoded by the NID2 gene. It is a member of the nidogen family of basement membrane proteins, playing a crucial role in the structure and function of the basement membrane, a specialized form of extracellular matrix. Nidogen-2, together with Nidogen-1, serves as a bridge linking the collagen IV and laminin networks, thus contributing to the integrity and stability of the basement membrane.
Structure[edit]
Nidogen-2 is a sulfated glycoprotein that shares a similar domain structure with Nidogen-1, including a series of globular domains (G1-G3) connected by rod-like elements. The G3 domain is responsible for the interaction with laminin, whereas the G2 domain mediates the binding to collagen IV. Despite their structural similarities, Nidogen-1 and Nidogen-2 have distinct binding affinities and are not functionally redundant.
Function[edit]
The primary function of Nidogen-2 is to contribute to the assembly and stability of the basement membrane, which provides support and anchorage to epithelial and endothelial cells. It plays a vital role in various physiological processes, including cell differentiation, migration, and filtration. Nidogen-2 is also involved in tissue repair and angiogenesis. Its interaction with other basement membrane components ensures the structural integrity necessary for tissue function and organ cohesion.
Genetics[edit]
The NID2 gene is located on human chromosome 14q22-q24. Mutations in this gene have not been prominently linked to human diseases, which suggests that there might be compensatory mechanisms, possibly through Nidogen-1, that mitigate the impact of Nidogen-2 deficiency. However, the precise genetic regulation and expression patterns of Nidogen-2 in various tissues and developmental stages require further investigation.
Clinical Significance[edit]
While direct associations between Nidogen-2 mutations and specific diseases are rare, changes in Nidogen-2 expression have been observed in certain pathological conditions. For instance, altered levels of Nidogen-2 have been reported in various types of cancer, where it may influence tumor progression and metastasis. Additionally, Nidogen-2 has been studied in the context of fibrosis and other diseases characterized by abnormal extracellular matrix deposition or remodeling.
Research Directions[edit]
Ongoing research aims to elucidate the detailed mechanisms by which Nidogen-2 contributes to basement membrane function and integrity. Studies are also exploring the potential of Nidogen-2 as a biomarker for certain diseases and its therapeutic implications, particularly in cancer and fibrotic diseases.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian